StockData
InfuSystem Holdings, Inc logo

InfuSystem Holdings, Inc (INFU) stock

INFUNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 15/304% below fair value
$14.72−0.07 (-0.47%)

Close on Nov 13, 2026Market cap $293.18MP/E 32.7Yield –

InfuSystem ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

InfuSystem's ebitda for the twelve months ending Sep 30, 2026 was $27.10M, up 12.0% year over year. For fiscal 2025 it was $25.21M, up 30.0% from the year before. The highest annual figure on record is $25.21M in fiscal 2025.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025$25.21M+30.0%
FY2024Dec 31, 2024$19.39M+16.8%
FY2023Dec 31, 2023$16.60M+10.5%
FY2022Dec 31, 2022$15.01M-13.9%
FY2021Dec 31, 2021$17.45M-23.7%
FY2020Dec 31, 2020$22.85M+44.0%
FY2019Dec 31, 2019$15.87M+35.4%
FY2018Dec 31, 2018$11.72M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$7.87M+10.9%
Q2 FY2026Jun 30, 2026$7.33M+2.9%
Q1 FY2026Mar 31, 2026$4.84M+23.0%
Q4 FY2025Dec 31, 2025$7.06M+17.0%
Q3 FY2025Sep 30, 2025$7.10M+10.7%
Q2 FY2025Jun 30, 2025$7.12M+45.6%
Q1 FY2025Mar 31, 2025$3.94M+91.6%
Q4 FY2024Dec 31, 2024$6.04M+37.4%
Q3 FY2024Sep 30, 2024$6.41M+34.5%
Q2 FY2024Jun 30, 2024$4.89M+12.6%
Q1 FY2024Mar 31, 2024$2.06M-33.6%
Q4 FY2023Dec 31, 2023$4.39M+6.3%
Q3 FY2023Sep 30, 2023$4.77M+8.7%
Q2 FY2023Jun 30, 2023$4.34M+20.3%
Q1 FY2023Mar 31, 2023$3.10M+7.1%
Q4 FY2022Dec 31, 2022$4.13M-21.4%
Q3 FY2022Sep 30, 2022$4.38M+29.3%
Q2 FY2022Jun 30, 2022$3.61M-17.2%
Q1 FY2022Mar 31, 2022$2.89M-34.9%
Q4 FY2021Dec 31, 2021$5.26M+15.1%
Q3 FY2021Sep 30, 2021$3.39M-50.3%
Q2 FY2021Jun 30, 2021$4.36M-45.8%
Q1 FY2021Mar 31, 2021$4.44M+29.3%
Q4 FY2020Dec 31, 2020$4.57M-0.7%
Q3 FY2020Sep 30, 2020$6.81M+42.2%
Q2 FY2020Jun 30, 2020$8.04M+101.4%
Q1 FY2020Mar 31, 2020$3.44M+38.2%
Q4 FY2019Dec 31, 2019$4.60M–
Q3 FY2019Sep 30, 2019$4.79M–
Q2 FY2019Jun 30, 2019$3.99M–
Q1 FY2019Mar 31, 2019$2.49M–

More InfuSystem figures

See a number that looks wrong?